Ppil3 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the Ppil3 protein, a member of the peptidyl-prolyl cis-trans isomerase (PPIase) family. Ppil3, like other PPIases, plays a crucial role in protein folding by catalyzing the cis-trans isomerization of proline residues in polypeptide chains. This isomerization is an essential step in the proper folding and functional conformation of many proteins, influencing various cellular processes such as signal transduction, cell cycle regulation, and gene expression. By modulating the activity of Ppil3, inhibitors can disrupt its isomerase function, thereby impacting the folding and maturation of its substrate proteins. This makes Ppil3 inhibitors valuable tools for studying the specific roles of Ppil3 in protein dynamics and cellular function.
The development of Ppil3 inhibitors involves several key stages, beginning with the detailed structural characterization of the Ppil3 protein. Techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance (NMR) spectroscopy are employed to determine the three-dimensional structure of Ppil3, focusing on the active site where isomerization occurs. Understanding this structure is crucial for identifying binding sites that can be targeted by inhibitors. Computational methods like molecular docking and virtual screening are then used to identify small molecules that can specifically bind to these sites, blocking the enzyme's activity. Once potential inhibitors are identified, they are synthesized and tested in vitro to evaluate their binding affinity, specificity, and inhibitory potency. These compounds are further refined through iterative cycles of chemical optimization to enhance their effectiveness and stability. By inhibiting Ppil3, researchers can explore its role in protein folding pathways, providing insights into how this enzyme influences cellular processes and contributes to the broader mechanisms of protein homeostasis. The study of Ppil3 inhibitors also offers a deeper understanding of the regulatory functions of PPIases within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A binds to the cyclophilins, inhibiting their peptidyl-prolyl isomerase activity, which could inhibit Ppil3's isomerase activity due to structural similarities. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK506 (Tacrolimus) binds to FKBP proteins and inhibits their isomerase activity; as Ppil3 shares similar enzymatic functions, FK506 may also inhibit Ppil3's activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds FKBP12, and while primarily known for mTOR inhibition, it might also inhibit similar proteins like Ppil3 by steric hindrance or allosteric effects. | ||||||
Halofuginone | 55837-20-2 | sc-507290 | 100 mg | $1775.00 | ||
Halofuginone inhibits prolyl-tRNA synthetase, potentially reducing the availability of proline-rich peptides for Ppil3, thereby indirectly inhibiting its activity. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64 is a cysteine protease inhibitor that could theoretically inhibit Ppil3's enzymatic activity if it has any interaction with cysteine residues in its active site. | ||||||
NSC 185058 | 39122-38-8 | sc-507531 | 1 mg | $85.00 | ||
NSC 185058 inhibits the activity of another isomerase, PIN1; it could inhibit Ppil3's isomerase activity if they have similar binding sites. | ||||||
UCH-L1 Inhibitor Inhibitor | 668467-91-2 | sc-356182 | 10 mg | $204.00 | 1 | |
LDN-57444 is a potent inhibitor of UCHL5, a deubiquitinating enzyme; it might inhibit Ppil3 if there is cross-reactivity due to similar enzyme pockets. | ||||||
L-685,458 | 292632-98-5 | sc-204042 sc-204042A | 1 mg 5 mg | $337.00 $1000.00 | 4 | |
L-685,458 is a gamma-secretase inhibitor, and while it is specific, it might inhibit Ppil3 if there are any similar aspartyl protease domains present. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a proteasome inhibitor, and if Ppil3 is involved in protein turnover or interacts with the ubiquitin-proteasome system, MG-132 might inhibit these interactions. | ||||||